Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pini TM et al. - Increased TZD exposure was not associated with a change in PSA, suggesting that TZD treatment for diabetes is unlikely to affect prostate cancer detection.

Related Articles

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09    Relevance Score: 87%

Combination of nateglinide with thiazolidinediones in Type 2 diabetes
Expert Review of Endocrinology & Metabolism, 11/10/09    Relevance Score: 84%

Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
Journal of Clinical Endocrinology and Metabolism, 11/10/09    Relevance Score: 84%

Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
Obesity, 11/17/09    Relevance Score: 80%

Fractures Associated With Diabetes
Ivanhoe, 10/02/09    Relevance Score: 80%

Today in Nephrology/Urology...keeping you current

Prospective studies of dietary alpha-linolenic acid intake and prostate cancer risk: a meta-analysis
Cancer Causes and Control, 11/25/09

25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Journal of the American Society of Nephrology, 11/25/09

Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial
BJU International, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address